D-Index & Metrics Best Publications
Samuel B. Ho

Samuel B. Ho

Mohammed Bin Rashid University of Medicine and Health Sciences
United Arab Emirates

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Gene
  • Cancer

His primary areas of investigation include Immunology, Mucin, Alcoholic liver disease, Liver disease and Internal medicine. His research in Immunology intersects with topics in Bronchoalveolar lavage and Intestinal mucosa. His work carried out in the field of Mucin brings together such families of science as Molecular biology and Gene expression, In situ hybridization.

He combines subjects such as Liver injury and Dysbiosis with his study of Alcoholic liver disease. His Liver disease research includes themes of Chronic liver disease, Cirrhosis and Steatohepatitis. The concepts of his Internal medicine study are interwoven with issues in Virus, Hepatitis C virus, Surgery and Alpha interferon.

His most cited work include:

  • Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress (749 citations)
  • Heterogeneity of Mucin Gene Expression in Normal and Neoplastic Tissues (611 citations)
  • Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review (377 citations)

What are the main themes of his work throughout his whole career to date?

Samuel B. Ho focuses on Internal medicine, Mucin, Immunology, Gastroenterology and Hepatitis C. His study looks at the relationship between Internal medicine and topics such as Surgery, which overlap with Colonoscopy. His work deals with themes such as Immunohistochemistry, Molecular biology and Epithelium, which intersect with Mucin.

His Immunology research includes elements of Liver disease, Alcoholic liver disease and Helicobacter pylori. His Liver disease research incorporates themes from Cirrhosis, Steatohepatitis and Dysbiosis. His Hepatitis C study deals with Depression intersecting with Psychological intervention and Physical therapy.

He most often published in these fields:

  • Internal medicine (54.01%)
  • Mucin (27.00%)
  • Immunology (25.52%)

What were the highlights of his more recent work (between 2014-2021)?

  • Internal medicine (54.01%)
  • Liver disease (14.24%)
  • Alcoholic liver disease (11.87%)

In recent papers he was focusing on the following fields of study:

Samuel B. Ho focuses on Internal medicine, Liver disease, Alcoholic liver disease, Gastroenterology and Cirrhosis. He regularly ties together related areas like Endocrinology in his Internal medicine studies. His study looks at the intersection of Liver disease and topics like Alcoholic hepatitis with Antibiotics, Cholesterol 7 alpha-hydroxylase, Chenodeoxycholic acid and Cholestasis.

He has included themes like Liver injury, Immunology, Chronic liver disease, Steatohepatitis and Dysbiosis in his Alcoholic liver disease study. Immunology and Intestinal mucosa are frequently intertwined in his study. His Dysbiosis research incorporates elements of Saturated fatty acid, Molecular biology and Intestinal permeability.

Between 2014 and 2021, his most popular works were:

  • Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases (332 citations)
  • A gp130-Src-YAP Module Links Inflammation to Epithelial Regeneration (329 citations)
  • Disordered methionine metabolism in MTAP/CDKN2A-deleted cancers leads to dependence on PRMT5. (200 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Gene
  • Cancer

His main research concerns Liver disease, Alcoholic liver disease, Internal medicine, Immunology and Dysbiosis. His Liver disease study combines topics in areas such as Chronic liver disease, Cirrhosis, Steatohepatitis and Alcoholic hepatitis. His biological study spans a wide range of topics, including Steatosis, Liver injury, Pathology, Andrology and Fatty liver.

His Internal medicine research is multidisciplinary, incorporating perspectives in Endocrinology, Interleukin 21 and Alcohol use disorder. His biological study deals with issues like Intestinal mucosa, which deal with fields such as Apoptosis and Epithelial Damage. Samuel B. Ho interconnects Intestinal permeability and Cecum in the investigation of issues within Dysbiosis.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Intestinal Goblet Cells and Mucins in Health and Disease: Recent Insights and Progress

Young S. Kim;Young S. Kim;Samuel B. Ho.
Current Gastroenterology Reports (2010)

1199 Citations

Heterogeneity of Mucin Gene Expression in Normal and Neoplastic Tissues

Samuel B. Ho;Gloria A. Niehans;Carolyn Lyftogt;Pei Sha Yan.
Cancer Research (1993)

941 Citations

Neuropsychiatric Symptoms Associated With Hepatitis C and Interferon Alpha: A Review

Eric Dieperink;Mark Willenbring;Samuel B. Ho.
American Journal of Psychiatry (2000)

576 Citations

Human gastric mucin. Identification of a unique species by expression cloning.

Neil W. Toribara;Anthony M. Roberton;Samuel B. Ho;Wen Lin Kuo.
Journal of Biological Chemistry (1993)

499 Citations

A gp130-Src-YAP Module Links Inflammation to Epithelial Regeneration

Koji Taniguchi;Koji Taniguchi;Koji Taniguchi;Li Wha Wu;Li Wha Wu;Sergei I. Grivennikov;Sergei I. Grivennikov;Petrus R. De Jong.
Nature (2015)

498 Citations

Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine kinases

Ying-Nan P. Chen;Matthew J. LaMarche;Ho Man Chan;Peter Fekkes.
Nature (2016)

394 Citations

Mucin Gene Expression in Normal, Preneoplastic, and Neoplastic Human Gastric Epithelium

Samuel B. Ho;Laurie L. Shekels;Neil W. Toribara;Young S. Kim.
Cancer Research (1995)

386 Citations

Peginterferon alfa-2b and weight-based or flat-dose ribavirin in chronic hepatitis C patients: A randomized trial

Ira M. Jacobson;Robert S. Brown;Bradley Freilich;Nezam Afdhal.
Hepatology (2007)

381 Citations

A novel role for murine IL-4 in vivo: induction of MUC5AC gene expression and mucin hypersecretion.

Ui-Angela Temann;Bhagi Prasad;Marianne W. Gallup;Carol Basbaum.
American Journal of Respiratory Cell and Molecular Biology (1997)

373 Citations

Localization of mucin (MUC2 and MUC3) messenger RNA and peptide expression in human normal intestine and colon cancer

Sae-Kyung Chang;Austin F. Dohrman;Carol B. Basbaum;Samuel B. Ho.
Gastroenterology (1994)

373 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Samuel B. Ho

Bernd Schnabl

Bernd Schnabl

University of California, San Diego

Publications: 103

Surinder K. Batra

Surinder K. Batra

University of Nebraska Medical Center

Publications: 58

Nicole Porchet

Nicole Porchet

University of Lille

Publications: 48

Nicholas W. Lukacs

Nicholas W. Lukacs

University of Michigan–Ann Arbor

Publications: 48

Fasiha Kanwal

Fasiha Kanwal

Baylor College of Medicine

Publications: 47

Sean P. Colgan

Sean P. Colgan

University of Colorado Anschutz Medical Campus

Publications: 33

Gunnar C. Hansson

Gunnar C. Hansson

University of Gothenburg

Publications: 31

Young S. Kim

Young S. Kim

University of California, San Francisco

Publications: 30

Celso A. Reis

Celso A. Reis

University of Porto

Publications: 29

R. Stokes Peebles

R. Stokes Peebles

Vanderbilt University

Publications: 27

Craig J. McClain

Craig J. McClain

University of Louisville

Publications: 27

Gregory J. Dore

Gregory J. Dore

University of New South Wales

Publications: 26

Isabelle Van Seuningen

Isabelle Van Seuningen

University of Lille

Publications: 24

Jason Grebely

Jason Grebely

University of New South Wales

Publications: 24

Ilene K. Gipson

Ilene K. Gipson

Harvard Medical School

Publications: 23

Steven M. Asch

Steven M. Asch

Stanford University

Publications: 23

Trending Scientists

Sheng Chen

Sheng Chen

University of Southampton

Sergio A. Velastin

Sergio A. Velastin

Queen Mary University of London

Tianpin Wu

Tianpin Wu

Argonne National Laboratory

Diego A. Moreno

Diego A. Moreno

Spanish National Research Council

Charles D. Derby

Charles D. Derby

Georgia State University

P. D. van Helden

P. D. van Helden

Stellenbosch University

Teresa Nunes

Teresa Nunes

University of Aveiro

Noam R. Izenberg

Noam R. Izenberg

Johns Hopkins University Applied Physics Laboratory

Gary A. Gill

Gary A. Gill

Pacific Northwest National Laboratory

Attila Szabo

Attila Szabo

Eötvös Loránd University

Stephanie D. Stepp

Stephanie D. Stepp

University of Pittsburgh

Donelson R. Forsyth

Donelson R. Forsyth

University of Richmond

Mark A. Lovell

Mark A. Lovell

University of Kentucky

David M. Boje

David M. Boje

New Mexico State University

P. Lukens

P. Lukens

Fermilab

Richard W Gran

Richard W Gran

University of Minnesota

Something went wrong. Please try again later.